Liraglutide and exenatide are potent medications classified as GLP-1 receptor agonists. These substances mimic the effects of naturally occurring glucagon-like peptide-1 (GLP-1), a hormone vital for regulating blood glucose levels. Both liraglutide and exenatide demonstrate efficacy in managing type 2 diabetes by prompting pancreatic beta cells to